TNFSF10 and colonic neoplasm: The combination of cardamonin, the most active compound, and TRAIL synergistically enhanced TRAIL-induced apoptosis of TRAIL-resistant human colon cancer (DLD1/TR) and human gastric adenocarcinoma cells.